Literature DB >> 30420251

Epidemiology of Lyme disease in Pennsylvania 2006-2014 using electronic health records.

Katherine A Moon1, Jonathan Pollak2, Annemarie G Hirsch3, John N Aucott4, Cara Nordberg5, Christopher D Heaney6, Brian S Schwartz7.   

Abstract

Lyme disease is the most common vector-borne disease in the United States. Electronic health record (EHR)-based research on Lyme disease is limited. We used Geisinger EHR data from 479,344 primary care patients in 38 Pennsylvania counties in 2006-2014 to compare EHR-based Lyme disease incidence rates to surveillance incidence rates, evaluate individual and community risk factors for incident Lyme disease, and to characterize the proportion of cases with diagnoses consistent with post-treatment Lyme disease syndrome in the EHR (PTLDSEHR). We primarily identified Lyme disease cases using diagnosis codes, serologic testing order codes, and medication orders but also completed subgroup analyses among those with positive serology and those with both diagnosis code and antibiotic treatment. We compared annual incidence rates from the EHR to surveillance by age, sex, and county. In case-control analyses, we compared cases to randomly selected controls (5:1) frequency-matched on year, age, and sex. We identified 9657 cases of Lyme disease, including 1791 cases with positive serology and 4992 cases with both diagnosis code and antibiotic treatment. Annual incidence rates in the EHR were 4.25-7.43 times higher than surveillance. In adjusted analyses, white non-Hispanic race/ethnicity (vs. black, Hispanic, or other) was associated with higher odds of Lyme disease (odds ratio [OR]: 2.06, 95% confidence interval [CI]: 1.73-2.44). Medical Assistance insurance use (always vs. never; OR: 0.77, 95% CI: 0.68-0.88), and higher community-level socioeconomic deprivation (quartile 4 vs. 1 OR: 0.50 (95% CI: 0.42-0.59) were associated with lower odds of Lyme disease. Within 4-52 weeks after Lyme disease diagnosis, 20.8% (n = 735) of cases with a diagnosis code and treatment had a diagnosis of malaise or fatigue, pain, or cognitive difficulties not present in the past 26 weeks. These results highlight the utility of EHR data for epidemiologic research on Lyme disease for case-finding, surveillance, risk factor evaluation, and characterization of PTLDS using EHR data.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Electronic health record; Epidemiology; Lyme borreliosis; Lyme disease; Post-treatment Lyme disease syndrome; Surveillance

Mesh:

Year:  2018        PMID: 30420251     DOI: 10.1016/j.ttbdis.2018.10.010

Source DB:  PubMed          Journal:  Ticks Tick Borne Dis        ISSN: 1877-959X            Impact factor:   3.744


  8 in total

Review 1.  Electronic Health Record Use in Public Health Infectious Disease Surveillance, USA, 2018-2019.

Authors:  Sarah J Willis; Noelle M Cocoros; Liisa M Randall; Aileen M Ochoa; Gillian Haney; Katherine K Hsu; Alfred DeMaria; Michael Klompas
Journal:  Curr Infect Dis Rep       Date:  2019-08-26       Impact factor: 3.725

Review 2.  Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease.

Authors:  Alison W Rebman; John N Aucott
Journal:  Front Med (Lausanne)       Date:  2020-02-25

3.  Risk Factors and Outcomes of Treatment Delays in Lyme Disease: A Population-Based Retrospective Cohort Study.

Authors:  Annemarie G Hirsch; Melissa N Poulsen; Cara Nordberg; Katherine A Moon; Alison W Rebman; John N Aucott; Christopher D Heaney; Brian S Schwartz
Journal:  Front Med (Lausanne)       Date:  2020-11-26

4.  Risk factors for Lyme disease stage and manifestation using electronic health records.

Authors:  Katherine A Moon; Jonathan S Pollak; Melissa N Poulsen; Christopher D Heaney; Annemarie G Hirsch; Brian S Schwartz
Journal:  BMC Infect Dis       Date:  2021-12-20       Impact factor: 3.090

5.  An electronic medical records study of population obesity prevalence in El Paso, Texas.

Authors:  Jennifer J Salinas; Jon Sheen; Navkiran Shokar; Justin Wright; Gerardo Vazquez; Ogechika Alozie
Journal:  BMC Med Inform Decis Mak       Date:  2022-02-22       Impact factor: 2.796

6.  Clinical characteristics and prognostic factors for Crohn's disease relapses using natural language processing and machine learning: a pilot study.

Authors:  Fernando Gomollón; Javier P Gisbert; Iván Guerra; Rocío Plaza; Ramón Pajares Villarroya; Luis Moreno Almazán; Mª Carmen López Martín; Mercedes Domínguez Antonaya; María Isabel Vera Mendoza; Jesús Aparicio; Vicente Martínez; Ignacio Tagarro; Alonso Fernández-Nistal; Sara Lumbreras; Claudia Maté; Carmen Montoto
Journal:  Eur J Gastroenterol Hepatol       Date:  2022-04-01       Impact factor: 2.566

7.  Neurological Pain, Psychological Symptoms, and Diagnostic Struggles among Patients with Tick-Borne Diseases.

Authors:  Sarah P Maxwell; Chris Brooks; Connie L McNeely; Kevin C Thomas
Journal:  Healthcare (Basel)       Date:  2022-06-23

8.  Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020).

Authors:  Laurence Geebelen; Tinne Lernout; Brecht Devleesschauwer; Benoît Kabamba-Mukadi; Veroniek Saegeman; Leïla Belkhir; Paul De Munter; Bénédicte Dubois; Rene Westhovens; Herman Van Oyen; Niko Speybroeck; Katrien Tersago
Journal:  BMC Infect Dis       Date:  2022-09-28       Impact factor: 3.667

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.